Timothy S. Burkoth
12Patents
11h-index
7Co-inventors
57Inventor score
Filing activity: Nov 23, 2005 → Aug 4, 2014
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8389578B2 | Composition and method for treating neurological disease | Human Necessities | 97 | Active |
| US8168209B2 | Method and composition for administering an NMDA receptor antagonist to a subject | Human Necessities | 33 | Active |
| US8796337B2 | Composition and method for treating neurological disease | Human Necessities | 27 | Active |
| US8895616B1 | Composition and method for treating neurological disease | Human Necessities | 21 | Active |
| US8889740B1 | Composition and method for treating neurological disease | Human Necessities | 21 | Active |
| US8895617B1 | Composition and method for treating neurological disease | Human Necessities | 21 | Active |
| US8895615B1 | Composition and method for treating neurological disease | Human Necessities | 21 | Active |
| US8895614B2 | Composition and method for treating neurological disease | Human Necessities | 21 | Active |
| US8895618B1 | Composition and method for treating neurological disease | Human Necessities | 21 | Active |
| US8426472B2 | Method and composition for administering an NMDA receptor antagonist to a subject | Human Necessities | 20 | Active |
| US8987333B2 | Composition and method for treating neurological disease | Human Necessities | 20 | Active |
| US8772255B2 | Cell transfecting formulations of small interfering RNA related compositions and methods of making and use | Chemistry; Metallurgy | 6 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.